Rational design of 6-(2,4-diaminopyrimidinyl)-1,4-benzoxazin-3-ones as small molecule renin inhibitors
- 1 September 2007
- journal article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry
- Vol. 15 (17), 5912-5949
- https://doi.org/10.1016/j.bmc.2007.05.069
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Ketopiperazine-based renin inhibitors: Optimization of the “C” ringBioorganic & Medicinal Chemistry Letters, 2006
- Benzyl ether structure–activity relationships in a series of ketopiperazine-based renin inhibitorsBioorganic & Medicinal Chemistry Letters, 2005
- Aliskiren, a Human Renin Inhibitor, Ameliorates Cardiac and Renal Damage in Double-Transgenic RatsHypertension, 2005
- Equipotent activity in both enantiomers of a series of ketopiperazine-based renin inhibitorsBioorganic & Medicinal Chemistry Letters, 2005
- Blood Pressure Lowering in Essential Hypertension With an Oral Renin Inhibitor, AliskirenHypertension, 2003
- Is there a future for renin inhibitors?Expert Opinion on Investigational Drugs, 2001
- Substituted piperidines - highly potent renin inhibitors due to induced fit adaptation of the active siteBioorganic & Medicinal Chemistry Letters, 1999
- Angiotensin‐Converting Enzyme Inhibitors and Cough: A Prospective Evaluation in Hypertension and in Congestive Heart FailureThe Journal of Clinical Pharmacology, 1994
- Maintenance of blood pressure by the renin–angiotensin system in normal manNature, 1981
- 2,4-Diamino-5-benzylpyrimidines as antibacterial agents. 4. 6-Substituted trimethoprim derivatives from phenolic Mannich intermediates. Application to the synthesis of trimethoprim and 3,5-dialkylbenzyl analogsJournal of Medicinal Chemistry, 1980